Results of Low-Dose Human Atrial Natriuretic Peptide Infusion in Nondialysis Patients With Chronic Kidney Disease Undergoing Coronary Artery Bypass Grafting

Ítems similars

• Continuous Low-Dose Infusion of Human Atrial Natriuretic Peptide in Patients With Left Ventricular Dysfunction Undergoing Coronary Artery Bypass Grafting
  per: Akira Sezai, et al.
  Publicat: (2010)
• Influence of Continuous Infusion of Low-Dose Human Atrial Natriuretic Peptide on Renal Function During Cardiac Surgery
  per: Akira Sezai, et al.
  Publicat: (2009)
• Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: New evidence from the PASCAL trial
  per: Akira Sezai, et al.
  Publicat: (2011)
• Optimal treatment strategy for type A acute aortic dissection with intramural hematoma
  per: Mitsumasa Hata, et al.
  Publicat: (2012)
• A Study on the Occurrence and Prevention of Perioperative Stroke after Coronary Artery Bypass Grafting
  per: Sezai, Akira, et al.
  Publicat: (2015)